994.0000 -0.45 (-0.05%)
NSE Oct 10, 2025 15:12 PM
Volume: 1.4M
 

Sharekhan
Cadila Healthcare Limited (Cadila) reported 22.2% y-o-y growth in total operating revenue to Rs. 3,496.3 crore (2% above estimate). Operating profit (adjusted for one-time cost of Rs. 70 related to acquisition) reported 14.8% y-o-y growth to Rs. 702 crore (6.5% above estimate); OPM declined by 130 BPS y-o-y to 20.1% (100 BPS above our estimate of 19.1%). Adjusted profit grew by 14.5% to Rs. 384.8 crore (11.9 % above estimates). Strong sales growth was mainly due to consumer wellness business in India (acquisition led). India human formulation reported 6%...
Zydus Lifesciences Ltd. is trading above its 200 day SMA of 949.6
More from Zydus Lifesciences Ltd.
Recommended